Vincerx Pharma Inc USD0.0001

Sell:$0.01Buy:$0.01No change

Prices delayed by at least 15 minutes
Sell:$0.01
Buy:$0.01
Change:No change
Deal now
Prices delayed by at least 15 minutes
Sell:$0.01
Buy:$0.01
Change:No change
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. It has a next generation bioconjugation platform, called VersAptx. Its product candidates include VIP943 (CD123-KSPi), VIP924 (CXCR5-KSPi), VIP236, and Enitociclib (positive transcription elongation factor beta (P-TEFb)/CDK9 inhibitor). Its VIP943 is developed using its VersAptx platform and combines an anti-CD123 antibody, a novel legumain-cleavable linker and a kinesin spindle protein inhibitor payload enhanced with CellTrapper technology. Enitociclib is a selective CDK9 inhibitor. Enitociclib effectively blocks P-TEFb-mediated activation of RNA polymerase II, preventing transcription of MCL1 and MYC, proteins associated with poor prognosis in various types of cancer.

Key people

Raquel E. Izumi
Acting Chief Executive Officer, Director
Kevin Haas
Acting Chief Financial Officer
Click to see more

Key facts

  • Shares in issue
    5.23m
  • EPIC
    VINC
  • ISIN
    US92731L3042
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $65,430.00
  • Employees
    12
  • Exchange
    Over The Counter
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview of the company, currency, shares in issue, EPIC, location, exchange, index, website, Data sourced by LSEG. Objective, Costs, Fee Structure, Key facts including Benchmark, Gross gearing are provided by MorningStar.